Preclinical Services for HIV Therapeutics

The National Institutes of Health awarded a competitive multiple-award, Indefinite Delivery/Indefinite Quantity contract to support preclinical services for HIV therapeutics. This award, associated with solicitation 75N93019R00021, utilizes NAICS code 541715 for Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) and PSC AJ12 for General Science and Technology R&D Services; General Science and Technology; Applied Research. The contract features a seven-year ordering period running from October 15, 2020, through October 14, 2027, with primary performance located in Iowa City, Iowa.

The scope of work is categorized under Task Area E, with most task orders expected to be cost-reimbursement or term/completion types due to the evolving nature of the scientific requirements. The government determined that fixed-price task orders are generally unfeasible because of the absence of precise specifications and the difficulty of accurately estimating costs in a dynamic research environment. This structure provides the flexibility necessary to address shifting needs, though fixed-price orders may be issued when appropriate. Robert Corno serves as the point of contact for this award notice, which was published on October 20, 2020.